US Patent 9597289 | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

U.S. Patents

PharmaCompass Sponsored Ads

Post An Enquiry

Jai Radhe Sales is your partner for all your sourcing needs.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

PharmaCompass Sponsored Ads

Post An Enquiry

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Xls

CATEGORY PAGE

Filters

FILTER :

filter Applicant Reset all filters

2 All

01 2SALERNO PHARMS

filter Patent Number Reset all filters

2 All

01 29597289

filter API Patent Reset all filters

2 All

01 2Blank

filter FDF Patent Reset all filters

2 All

01 2Y

filter Expiration Date Reset all filters

2 All

01 22030-02-23

01

SALERNO PHARMS

Medlab Asia & Asia Health

Not Confirmed

SALERNO PHARMS

Country

Medlab Asia & Asia Health

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-02-23

SIMVASTATIN

US Patent Number : 9597289

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 206679

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-02-23

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

SALERNO PHARMS

Medlab Asia & Asia Health

Not Confirmed

SALERNO PHARMS

Country

Medlab Asia & Asia Health

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-02-23

SIMVASTATIN

US Patent Number : 9597289

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 206679

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-02-23

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?